COMP <GO>
CHE vs LFST // DIVIDEND YIELD & FCF PAYOUT SAFETY
Chemed Corp (NYSE) VS. LifeStance Health Group Inc. (NASDAQ) • 15-METRIC TALLY: CHE 8
— LFST 3
▲ DIVIDEND YIELD & FCF PAYOUT SAFETY LEADER: CHE
LAST: $541.92 (+1.61%) • MKT CAP: $7.08B
dividend-safety
0.45%
LAST: $13.64 (+1.83%) • MKT CAP: $5.21B
dividend-safety
0.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CHE VS. LFST)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CHE | LFST | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 32.50% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 23.40% | 1.20% | +22.20 | CHE | /roic <GO> |
| EV/EBITDA & P/E Valuation | 18.5x | 95.3x | -76.80 | CHE | /valuation <GO> |
| Free Cash Flow Yield | 4.60% | 2.11% | +2.49 | CHE | /fcf-yield <GO> |
| Operating Margin | 13.40% | 1.70% | +11.70 | CHE | /operating-margins <GO> |
| Net Profit Margin | 0.00% | 0.70% | -0.70 | LFST | /net-margins <GO> |
| Revenue Growth (YoY) | 65.30% | 13.90% | +51.40 | CHE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety ACTIVE | 0.45% | 0.00% | +0.45 | CHE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 12.68 | 4.84 | +7.84 | CHE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | LFST | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 64.9 | 67.6 | -2.70 | LFST | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.08 | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $7.08B | $5.21B | $1.87B | CHE | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CHE REV | LFST REV | CHE GROSS % | LFST GROSS % | CHE FCF | LFST FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.53B | $1.42B | 32.5% | — | $325.5M | $110.0M |
| FY 2024 | $1.53B | $1.25B | — | — | $368.0M | $85.7M |
| FY 2023 | $1.32B | $1.06B | — | — | $271.1M | -$16.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CHE // BETA 1.08
LFST // BETA —